Press Resease

Oligonucleotide Synthesis Market - Global Industry Analysis

Oligonucleotide Synthesis Market by Offering (Equipment, Reagents and Consumables, and Synthesized Oligonucleotides [Product and Services), by Application (Research, Therapeutics, and Diagnostics), and by End-User (Academic Research Institutes, Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018—2026

Published Date: 23-Jan-2019 Category: Biotechnology Report Format : PDF Pages: 110 Report Code: ZMR-485 Status : Published

Global oligonucleotide synthesis market expected to generate around USD 3,697 million by 2026, at a CAGR of around 10.6% between 2019 and 2026. Small fragments of nucleic acids that are synthesized via enzyme chemistry and genetic engineering are known as oligonucleotides.

Description

The report covers a forecast and an analysis of the oligonucleotide synthesis market on a global and regional level. The study provides historical data for 2016 and 2017 along with a forecast from 2019 to 2026 based on revenue (USD Million). The study includes the drivers and restraints of the oligonucleotide synthesis market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the oligonucleotide synthesis market on a global level.

In order to give the users of this report a comprehensive view of the oligonucleotide synthesis market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Oligonucleotide Synthesis Market

The report provides company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research& development, and regional expansion of major participants involved in the market on a global and regional basis.

The study provides a decisive view of the oligonucleotide synthesis market by segmenting the market based on offering, application, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2026. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further divided into major countries.

Some leading players of the global oligonucleotide synthesis market include ATD Bio Ltd., BianoScience GmbH, BioSpring GmbH, Bioneer Corporation, Bio-Synthesis, Inc., Creative Biogene, Dalton Pharma Services, Eurofins Genomics, GE, GeneDesign, Inc., GenScript, IBA GmbH, Integrated DNA Technologies, Inc., Kaneka Eurogentec S.A., LGC Biosearch Technologies, Merck KGaA, Microsynth AG, Syngene, Thermo Fisher Scientific, Inc., TriLink BioTechnologies, LLC, and Twist Bioscience.

This report segments the global oligonucleotide synthesis market into:

Global Oligonucleotide Synthesis Market: Offering Analysis

  • Equipment
  • Reagents and Consumables
  • Synthesized Oligonucleotides
    • By Product
      • Primers
      • Probes
      • Large-Scale Synthesis Oligonucleotides
      • Intermediate-Scale Synthesis Oligonucleotides
      • Linkers and Adaptors
      • Others
    • By Service
      • Custom/Specialty Oligonucleotides
        • Modified
        • Non-Modified
      • Pre-Designed Oligonucleotides

Global Oligonucleotide Synthesis Market: Application Analysis

  • Research
    • Polymerase Chain Reaction
    • qPCR
    • Next Generation Sequencing
    • Others
  • Therapeutics
    • Antisense Oligonucleotides
    • RNAi
    • Nucleic Acid Aptamers
    • Immunotherapy Applications
  • Diagnostics

Global Oligonucleotide Synthesis Market: End-User Analysis

  • Academic Research Institutes
  • Diagnostic Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Others

Global Oligonucleotide Synthesis Market: Regional Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global oligonucleotide synthesis market,2016-2026 (USD Million)
    • 2.2. Global oligonucleotide synthesis market: snapshot
  •  
  • Chapter 3. Oligonucleotide Synthesis Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Global oligonucleotide synthesis market drivers: impact analysis
      • 3.2.2. Increasing government investments and R&D expenditure in pharma and biotech companies
      • 3.2.3. Strong pipeline of antisense oligonucleotides
      • 3.2.4. Large number of players operating in the market
    • 3.3. Market Restraints
      • 3.3.1. Global oligonucleotide synthesis market restraints: impact analysis
      • 3.3.2. In-house development of oligonucleotides hindering revenue growth
      • 3.3.3. Price erosion of synthesized oligonucleotides
    • 3.4. Opportunities
      • 3.4.1. Growing focus on personalized medicine
      • 3.4.2. Emerging Asian market
    • 3.5. Porter’s Five Forces Analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. The threat from new entrants
      • 3.5.4. The threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis, by offering
      • 3.6.2. Market attractiveness analysis, by application
      • 3.6.3. Market attractiveness analysis, by end-user
      • 3.6.4. Market attractiveness analysis, by region
  •  
  • Chapter 4. Global Oligonucleotide Synthesis Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global oligonucleotide synthesis market: company market share, 2017
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New therapy launch
      • 4.2.3. Agreements, partnerships, collaborations, and joint ventures
      • 4.2.4. Research and development and regional expansion
  •  
  • Chapter 5. Global Oligonucleotide Synthesis Market - Offering Segment Analysis
    • 5.1. Global oligonucleotide synthesis market: offering overview
      • 5.1.1. Global oligonucleotide synthesis market revenue share, by offering, 2016 and 2026
    • 5.2. Equipment
      • 5.2.1. Global oligonucleotide synthesis market for equipment, 2016 - 2026 (USD Million)
    • 5.3. Reagents and Consumables
      • 5.3.1. Global oligonucleotide synthesis market for reagents and consumables,2016-2026 (USD Million)
    • 5.4. Synthesized Oligonucleotides
      • 5.4.1. Global oligonucleotide synthesis market for synthesized oligonucleotides, 2016 - 2026 (USD Million)
      • 5.4.1.1. Product
        • 5.4.1.1.1. Global synthesized oligonucleotides market for product, 2016-2026(USD Billion)
      • 5.4.1.2. Services
        • 5.4.1.2.1. Global synthesized oligonucleotides market for services, 2016-2026(USD Billion)
  •  
  • Chapter 6. Global Oligonucleotide Synthesis Market - Application Analysis
    • 6.1. Global oligonucleotide synthesis market: Application Overview
      • 6.1.1. Global oligonucleotide synthesis market revenue share, by application, 2016 and 2026
    • 6.2. Research
      • 6.2.1. Global oligonucleotide synthesis market for research, 2016-2026 (USD Million)
        • 6.2.1.1. Polymerase Chain Reaction
          • 6.2.1.1.1. Global research market for polymerase chain reaction, 2016-2026(USD Billion)
        • 6.2.1.2. qPCR
          • 6.2.1.2.1. Global research market for qPCR, 2016-2026(USD Billion)
        • 6.2.1.3. Next Generation Sequencing
          • 6.2.1.3.1. Global research market for next-generation sequencing, 2016-2026(USD Billion)
        • 6.2.1.4. Others
          • 6.2.1.4.1. Global research market for others, 2016-2026(USD Billion)
    • 6.3. Therapeutics
      • 6.3.1. Global oligonucleotide synthesis market for therapeutics, 2016-2026 (USD Million)
        • 6.3.1.1. Antisense Oligonucleotides
          • 6.3.1.1.1. Global therapeutics market for antisense oligonucleotides, 2016-2026(USD Billion)
        • 6.3.1.2. RNAi
          • 6.3.1.2.1. Global therapeutics market for RNAi, 2016-2026(USD Billion)
        • 6.3.1.3. Nucleic Acid Aptamers
          • 6.3.1.3.1. Global therapeutics market for nucleic acid Aptamers, 2016-2026(USD Billion)
        • 6.3.1.4. Immunotherapy Applications
          • 6.3.1.4.1. Global therapeutics market for immunotherapy application, 2016-2026(USD Billion)
    • 6.4. Diagnostics
      • 6.4.1. Global oligonucleotide synthesis market for diagnostics, 2016-2026 (USD Million)
  •  
  • Chapter 7. Global Oligonucleotide Synthesis Market - End-user Analysis
    • 7.1. Global oligonucleotide synthesis market: end-user overview
      • 7.1.1. Global oligonucleotide synthesis market revenue share, by end-user, 2017 and 2026
    • 7.2. Academic Research Institute
      • 7.2.1. Global oligonucleotide synthesis market for academic research institute, 2016-2026 (USD Million)
    • 7.3. Diagnostic Laboratories
      • 7.3.1. Global oligonucleotide synthesis market for diagnostic laboratories, 2016 - 2026 (USD Million)
    • 7.4. Pharmaceutical and Biotechnology Companies
      • 7.4.1. Global oligonucleotide synthesis market for pharmaceutical and biotechnology companies, 2016-2026 (USD Million)
    • 7.5. Others
      • 7.5.1. Global oligonucleotide synthesis market for others, 2016-2026 (USD Million)
  •  
  • Chapter 8. Global Oligonucleotide Synthesis Market - Regional Analysis
    • 8.1. Global oligonucleotide synthesis market: regional overview
      • 8.1.1. Global oligonucleotide synthesis market revenue share, by region, 2016 and 2026
    • 8.2. North America
      • 8.2.1. North America oligonucleotide synthesis market revenue, by offering, 2016 - 2026 (USD Million)
      • 8.2.2. North America oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
      • 8.2.3. North America oligonucleotide synthesis market revenue, by end-user, 2016-2026 (USD Million)
      • 8.2.4. The U.S.
        • 8.2.4.1. The U.S. oligonucleotide synthesis market revenue, by offering, 2016 - 2026 (USD Million)
        • 8.2.4.2. The U.S. oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
        • 8.2.4.3. The U.S. oligonucleotide synthesis market revenue, by end-user, 2016 - 2026 (USD Million)
      • 8.2.5. Canada
        • 8.2.5.1. Canada oligonucleotide synthesis market revenue, by offering, 2016 - 2026 (USD Million)
        • 8.2.5.2. Canada oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
        • 8.2.5.3. Canada oligonucleotide synthesis market revenue, by end-user, 2016 - 2026 (USD Million)
    • 8.3. Europe
      • 8.3.1. Europe oligonucleotide synthesis market revenue, by offering, 2016 - 2026 (USD Million)
      • 8.3.2. Europe oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
      • 8.3.3. Europe oligonucleotide synthesis market revenue, by end-user, 2016-2026 (USD Million)
      • 8.3.4. UK
        • 8.3.4.1. UK oligonucleotide synthesis market revenue, by offering, 2016-2026 (USD Million)
        • 8.3.4.2. UK oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
        • 8.3.4.3. UK oligonucleotide synthesis market revenue, by end-user, 2016 - 2026 (USD Million)
      • 8.3.5. Germany
        • 8.3.5.1. Germany oligonucleotide synthesis market revenue, by offering, 2016 - 2026 (USD Million)
        • 8.3.5.2. Germany oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
        • 8.3.5.3. Germany oligonucleotide synthesis market revenue, by end-user, 2016 - 2026 (USD Million)
      • 8.3.6. France
        • 8.3.6.1. France oligonucleotide synthesis market revenue, by offering, 2016 - 2026 (USD Million)
        • 8.3.6.2. France oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
        • 8.3.6.3. France oligonucleotide synthesis market revenue, by end-user, 2016 - 2026 (USD Million)
      • 8.3.7. Italy
        • 8.3.7.1. Italy oligonucleotide synthesis market revenue, by offering, 2016-2026 (USD Million)
        • 8.3.7.2. Italy oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
        • 8.3.7.3. Italy oligonucleotide synthesis market revenue, by end-user, 2016-2026 (USD Million)
      • 8.3.8. Spain
        • 8.3.8.1. Spain oligonucleotide synthesis market revenue, by offering, 2016-2026 (USD Million)
        • 8.3.8.2. Spain oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
        • 8.3.8.3. Spain oligonucleotide synthesis market revenue, by end-user, 2016-2026 (USD Million)
      • 8.3.9. Rest of Europe
        • 8.3.9.1. Rest of Europe oligonucleotide synthesis market revenue, by offering, 2016-2026 (USD Million)
        • 8.3.9.2. Rest of Europe oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
        • 8.3.9.3. Rest of Europe oligonucleotide synthesis market revenue, by end-user, 2016 - 2026 (USD Million)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific oligonucleotide synthesis market revenue, by offering, 2016 - 2026 (USD Million)
      • 8.4.2. Asia Pacific oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
      • 8.4.3. Asia Pacific oligonucleotide synthesis market revenue, by end-user, 2016 - 2026 (USD Million)
      • 8.4.4. China
        • 8.4.4.1. China oligonucleotide synthesis market revenue, by offering, 2016 - 2026 (USD Million)
        • 8.4.4.2. China oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
        • 8.4.4.3. China oligonucleotide synthesis market revenue, by end-user, 2016 - 2026 (USD Million)
      • 8.4.5. Japan
        • 8.4.5.1. Japan oligonucleotide synthesis market revenue, by offering, 2016 - 2026 (USD Million)
        • 8.4.5.2. Japan oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
        • 8.4.5.3. Japan oligonucleotide synthesis market revenue, by end-user, 2016 - 2026 (USD Million)
      • 8.4.6. India
        • 8.4.6.1. India oligonucleotide synthesis market revenue, by offering, 2016 - 2026 (USD Million)
        • 8.4.6.2. India oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
        • 8.4.6.3. India oligonucleotide synthesis market revenue, by end-user, 2016 - 2026 (USD Million)
      • 8.4.7. Southeast Asia
        • 8.4.7.1. Southeast Asia oligonucleotide synthesis market revenue, by offering, 2016-2026 (USD Million)
        • 8.4.7.2. Southeast Asia oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
        • 8.4.7.3. Southeast Asia oligonucleotide synthesis market revenue, by end-user, 2016-2026 (USD Million)
      • 8.4.8. Rest of Asia Pacific
        • 8.4.8.1. Rest of Asia Pacific oligonucleotide synthesis market revenue, by offering, 2016 - 2026 (USD Million)
        • 8.4.8.2. Rest of Asia Pacific oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
        • 8.4.8.3. Rest of Asia Pacific oligonucleotide synthesis market revenue, by end-user, 2016 - 2026 (USD Million)
    • 8.5. Latin America
      • 8.5.1. Latin America oligonucleotide synthesis market revenue, by offering, 2016 - 2026 (USD Million)
      • 8.5.2. Latin America oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
      • 8.5.3. Latin America oligonucleotide synthesis market revenue, by end-user, 2016 - 2026 (USD Million)
      • 8.5.4. Brazil
        • 8.5.4.1. Brazil oligonucleotide synthesis market revenue, by offering, 2016 - 2026 (USD Million)
        • 8.5.4.2. Brazil oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
        • 8.5.4.3. Brazil oligonucleotide synthesis market revenue, by end-user, 2016 - 2026 (USD Million)
      • 8.5.5. Rest of Latin America
        • 8.5.5.1. Rest of Latin America oligonucleotide synthesis market revenue, by offering, 2016 - 2026 (USD Million)
        • 8.5.5.2. Rest of Latin America oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
        • 8.5.5.3. Rest of Latin America oligonucleotide synthesis market revenue, by end-user, 2016 - 2026 (USD Million)
    • 8.6. The Middle East and Africa
      • 8.6.1. The Middle East and Africa oligonucleotide synthesis market revenue, by offering, 2016 - 2026 (USD Million)
      • 8.6.2. The Middle East and Africa oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
      • 8.6.3. The Middle East and Africa oligonucleotide synthesis market revenue, by end-user, 2016 - 2026 (USD Million)
      • 8.6.4. GCC countries
        • 8.6.4.1. GCC countries oligonucleotide synthesis market revenue, by offering, 2016-2026 (USD Million)
        • 8.6.4.2. GCC countries oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
        • 8.6.4.3. GCC countries oligonucleotide synthesis market revenue, by end-user, 2016-2026 (USD Million)
      • 8.6.5. South Africa
        • 8.6.5.1. South Africa oligonucleotide synthesis market revenue, by offering, 2016-2026 (USD Million)
        • 8.6.5.2. South Africa oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
        • 8.6.5.3. South Africa oligonucleotide synthesis market revenue, by end-user, 2016-2026 (USD Million)
      • 8.6.6. Rest of the Middle East and Africa
        • 8.6.6.1. Rest of the Middle East and Africa oligonucleotide synthesis market revenue, by offering, 2016-2026 (USD Million)
        • 8.6.6.2. Rest of the Middle East and Africa oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
        • 8.6.6.3. Rest of the Middle East and Africa oligonucleotide synthesis market revenue, by end-user, 2016-2026 (USD Million)
  •  
  • Chapter 9. Company Profile
    • 9.1. Agilent Technologies, Inc.
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product portfolio
      • 9.1.4. Business strategy
      • 9.1.5. Recent developments
    • 9.2. ATD Bio Ltd.
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Product portfolio
      • 9.2.4. Business strategy
      • 9.2.5. Recent developments
    • 9.3. BianoScience GmbH
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Product portfolio
      • 9.3.4. Business strategy
      • 9.3.5. Recent developments
    • 9.4. BioSpring GmbH
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product portfolio
      • 9.4.4. Business strategy
      • 9.4.5. Recent developments
    • 9.5. BIONEER CORPORATION
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product portfolio
      • 9.5.4. Business strategy
      • 9.5.5. Recent developments
    • 9.6. Bio-Synthesis, Inc.
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product portfolio
      • 9.6.4. Business strategy
      • 9.6.5. Recent developments
    • 9.7. Creative Biogene
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Product portfolio
      • 9.7.4. Business strategy
      • 9.7.5. Recent developments
    • 9.8. Dalton Pharma Services
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Product portfolio
      • 9.8.4. Business strategy
      • 9.8.5. Recent developments
    • 9.9. Eurofins Genomics
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Product portfolio
      • 9.9.4. Business strategy
      • 9.9.5. Recent developments
    • 9.10. GE
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Product portfolio
      • 9.10.4. Business strategy
      • 9.10.5. Recent developments
    • 9.11. GeneDesign, Inc.
      • 9.11.1. Overview
      • 9.11.2. Financials
      • 9.11.3. Product portfolio
      • 9.11.4. Business strategy
      • 9.11.5. Recent developments
    • 9.12. GenScript
      • 9.12.1. Overview
      • 9.12.2. Financials
      • 9.12.3. Product portfolio
      • 9.12.4. Business strategy
      • 9.12.5. Recent developments
    • 9.13. IBA GmbH
      • 9.13.1. Overview
      • 9.13.2. Financials
      • 9.13.3. Product portfolio
      • 9.13.4. Business strategy
      • 9.13.5. Recent developments
    • 9.14. Integrated DNA Technologies, Inc.
      • 9.14.1. Overview
      • 9.14.2. Financials
      • 9.14.3. Product portfolio
      • 9.14.4. Business strategy
      • 9.14.5. Recent developments
    • 9.15. Kaneka Eurogentec S.A.
      • 9.15.1. Overview
      • 9.15.2. Financials
      • 9.15.3. Product portfolio
      • 9.15.4. Business strategy
      • 9.15.5. Recent developments
    • 9.16. LGC Biosearch Technologies
      • 9.16.1. Overview
      • 9.16.2. Financials
      • 9.16.3. Product portfolio
      • 9.16.4. Business strategy
      • 9.16.5. Recent developments
    • 9.17. Merck KGaA
      • 9.17.1. Overview
      • 9.17.2. Financials
      • 9.17.3. Product portfolio
      • 9.17.4. Business strategy
      • 9.17.5. Recent developments
    • 9.18. Microsynth AG
      • 9.18.1. Overview
      • 9.18.2. Financials
      • 9.18.3. Product portfolio
      • 9.18.4. Business strategy
      • 9.18.5. Recent developments
    • 9.19. Syngene
      • 9.19.1. Overview
      • 9.19.2. Financials
      • 9.19.3. Product portfolio
      • 9.19.4. Business strategy
      • 9.19.5. Recent developments
    • 9.20. Thermo Fisher Scientific, Inc.
      • 9.20.1. Overview
      • 9.20.2. Financials
      • 9.20.3. Product portfolio
      • 9.20.4. Business strategy
      • 9.20.5. Recent developments
    • 9.21. TriLink BioTechnologies, LLC
      • 9.21.1. Overview
      • 9.21.2. Financials
      • 9.21.3. Product portfolio
      • 9.21.4. Business strategy
      • 9.21.5. Recent developments
    • 9.22. Twist Bioscience
      • 9.22.1. Overview
      • 9.22.2. Financials
      • 9.22.3. Product portfolio
      • 9.22.4. Business strategy
      • 9.22.5. Recent developments

Methodology

Free Analysis

Small fragments of nucleic acids that are synthesized via enzyme chemistry and genetic engineering are known as oligonucleotides. These are mainly used in laboratories for diagnostics, therapeutics, and in academic and industrial research. Oligonucleotides are also used for initial screening of target validation and drug production. The process of oligonucleotides synthesis occurs either individually via DNA synthesizers or commercially to provide services for various end-users or self-consumption. The improvement in oligonucleotide synthesis, automation, and amplification has completely revolutionized the biological research domain. Nowadays, it is possible to get customizations and specific sequences online easily and at any required time. Companies are focusing on improving their services via technology improvisations with cost control to get more traction.

Major oligonucleotides manufacturers are expanding their businesses through collaboration with pharmaceutical manufacturers. Subsequent numbers of oligos are in a later phase of clinical trials that are targeted at various conditions, such as cardiovascular diseases, muscle dystrophies, ocular disorders, and majorly cancer. This, in turn, has further anticipated the regulatory approvals for multiple oligonucleotide-based therapies. The oligonucleotides synthesis market is likely to benefit from the constant growth of gene editing and genomics markets, as there are a large number of advancements related to genetic tools for simplifying the synthesis of oligonucleotide process. Furthermore, the improvements in patient response systems are also generating a multitude of data, thereby, furthering the oligonucleotide synthesis market in the future.

Global Oligonucleotide Synthesis Market

The global market for oligonucleotide synthesis is segmented on the basis of the offering, application, and end-user. By offering, the oligonucleotide synthesis market is segmented into equipment, reagents and consumables, and synthesized oligonucleotides. The synthesized oligonucleotides market is further divided into product and services. The products segment includes large-scale synthesis oligonucleotides, probes, primers, linkers and adaptors, intermediate-scale synthesis oligonucleotides, and others. The services segment includes custom/specialty oligonucleotides (modified and non-modified oligonucleotides) and pre-designed oligonucleotides. By application, this global market includes research, therapeutics, and diagnostics. The research segment includes polymerase chain reaction, qPCR, next-generation sequencing, and others. The therapeutics segment includes antisense oligonucleotides, RNAi, nucleic acid aptamers, and immunotherapy applications. By end-user, the market includes pharmaceutical and biotechnology companies, diagnostic laboratories, academic research institutes, and others.

By region, the global oligonucleotide synthesis market includes North America, Latin America, Asia Pacific, Europe, and the Middle East and Africa. North America is anticipated to dominate the market for oligonucleotide synthesis and hold a major share of the oligonucleotide synthesis market over the forecast timeline. This regional dominance can be attributed to the growing prevalence of genetic diseases and the subsequent demand for new and advanced drugs. The Asia Pacific and European regions are likely to register a rise in their market valuation over the estimated timeframe. The Asia Pacific oligonucleotide synthesis market is projected to be driven by the strong presence of innumerable companies offering consumables and reagents for oligonucleotide synthesis and the increased need for better health outcomes, the rising prevalence of infectious and chronic diseases, and the availability of improved healthcare infrastructure in the region.

Some leading players of the global oligonucleotide synthesis market include ATD Bio Ltd., BianoScience GmbH, BioSpring GmbH, Bioneer Corporation, Bio-Synthesis, Inc., Creative Biogene, Dalton Pharma Services, Eurofins Genomics, GE, GeneDesign, Inc., GenScript, IBA GmbH, Integrated DNA Technologies, Inc., Kaneka Eurogentec S.A., LGC Biosearch Technologies, Merck KGaA, Microsynth AG, Syngene, Thermo Fisher Scientific, Inc., TriLink BioTechnologies, LLC, and Twist Bioscience.

 

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social